Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries

European Journal of Pharmacology

Volumn 402, Issue 1-2, 2000, Pages 209-211

  Katano, Yumi ^a   Ishihata, Akira ^a   Aita, Tomomi ^a   Ogaki, Tomoko ^a   Horie, Tatsuya ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Coronary artery; Urotensin II; Vasodilatation

Indexed keywords

DICLOFENAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; UROTENSIN II; VASOCONSTRICTOR AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; NOS3 PROTEIN, HUMAN; NOS3 PROTEIN, RAT; UROTENSIN; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DRUG EFFECT; HEART PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; VASOCONSTRICTION; ANIMAL; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; FISCHER 344 RAT; HUMAN; IN VITRO STUDY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CORONARY VESSELS; DICLOFENAC; ENZYME INHIBITORS; HUMANS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITROARGININE; RATS; RATS, INBRED F344; UROTENSINS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0034683175     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00506-9     Document Type: Article

References (8)

1. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., Louden C.S., Foley J.J., Sauermelch C.F., Coatney R.W., Ao Z., Disa J., Holmes S.D., Stadel J.M., Martin J.D., Liu W.S., Glover G.I., Wilson S., McNulty D.E., Ellis C.E., Elshourbagy N.A., Shabon U., Trill J.J., Hay D.W., Ohlstein E.H., Bergsma D.J., Douglas S.A. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature. 401:1999;282-286.
2. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J.C., Conlon J.M., Bern H.A., Vaudry H. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15803-15808.
3. Gibson A. Complex effects of Gillichthys urotensin II on rat aortic strips. Br. J. Pharmacol. 91:1987;205-212.
4. Gibson A., Wallace P., Bern H.A. Cardiovascular effects of urotensin II in anesthetized and pithed rats. Gen. Comp. Endocrinol. 64:1986;435-439.
5. Ishihata A., Katano Y., Nakamura M., Doi K., Tasaki K., Ono A. Differential modulation of nitric oxide and prostacyclin release in senescent rat heart stimulated by angiotensin II. Eur. J. Pharmacol. 382:1999;19-26.
6. Itoh H., Itoh Y., Rivier J., Lederis K. Contraction of major artery segments of rat by fish neuropeptide urotensin II. Am. J. Physiol. 252:1987;r361-366.
7. Liu Q., Pong S.S., Zeng Z., Zhang Q., Howard A.D., Williams D.J., Davidoff M., Wang R., Austin C.P., McDonald T.P., Bai C., George S.R., Evans J.F., Caskey C.T. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem. Biophys. Res. Commun. 266:1999;174-178.
8. MacLean M.R., Alexander D., Stirrat A., Gallagher M., Douglas S.A., Ohlstein E.H., Morecroft I., Polland K. Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. Br. J. Pharmacol. 130:2000;201-204.